Skip to main content

Table 2 SNPs with allele-specific expression in the LV

From: Allele-specific expression in the human heart and its application to postoperative atrial fibrillation and myocardial ischemia

SNP Gene Chr Location Samples Reads REF/ALT + REF FDR adj. p value
rs76148815 MTR 1 237,063,719 92 8029 0.07 5 × 10–217
rs7772210 MTCH1 6 36,936,771 58 8199 0.91 1 × 10–209
rs2260914 ZSCAN18 19 58,598,784 50 2967 0.07 2 × 10–199
rs1046138 PKP2 12 32,944,162 64 21,767 0.92 8 × 10–194
rs2075846 OXA1L 14 23,239,512 66 14,818 0.92 5 × 10–178
rs200574632 MUL1 1 20,826,784 64 3728 0.94 3 × 10–127
rs17850531 ECHDC3 10 11,805,339 56 2467 0.97 5 × 10–109
rs164577 SLC30A5 5 68,417,755 84 1374 0.03 8 × 10–107
rs312185 AP2S1 19 47,342,867 76 2040 0.96 2 × 10–114
rs2586306 ABR 17 909,451 76 2626 0.06 4 × 10–114
  1. The table shows the ten SNPs with the most significant ASE in the LV samples (n = 3774), the gene they are located within, the genomic location, number of heterozygous samples and reads overlapping the SNP available for ASE calling, the REF/ALT + REF ratio, and the FDR-adjusted p value for ASE